PMID- 25095537 OWN - NLM STAT- MEDLINE DCOM- 20140909 LR - 20140806 IS - 0890-9016 (Print) IS - 0890-9016 (Linking) DP - 2013 TI - Immunoglobulin G subclass analysis of HLA donor specific antibodies in heart and renal transplant recipients. PG - 413-22 AB - Immunoglobulin G (IgG) subclasses IgG1 (G1) and lgG3 (G3) can induce complement dependent cytotoxicity (CDC) and bind to Fc receptors (FcR), which induces phagocytosis and antibody dependent cellular cytotoxicity. In contrast, IgG2 has low CDC activity, lgG4 (G4) has no CDC activity, and neither binds high affinity FcR. Seven transplant recipients were analyzed for G1- G4 human leukocyte antigen (HLA) donor-specific antibodies (DSAs); six had active rejection and one had stable function. Patients with rejection had equal numbers of DSAs, which were G1 and G3, but no G4. The predominant DSAs were directed against HLA Class II proteins. Even with successful anti-rejection therapy, DSA persisted, albeit in several instances with lowered levels. Our findings are consistent with the presence of CDC-inducing G1 and G3 subclass DSAs during rejection. One heart transplant recipient followed for over 42 months had consistent, continuous G4 HLA DSA and stable function. We hypothesize that the presence of G4 DSA in the heart transplant recipient is akin to the allergen specific G4 that has been found in allergic desensitization tolerance, controlled by regulatory T-cells, and that manipulating G4 class switching through HLA antigen desensitzation could produce a tolerant state. FAU - Cicciarelli, James C AU - Cicciarelli JC FAU - Kasahara, Noriyuki AU - Kasahara N FAU - Lemp, Nathan A AU - Lemp NA FAU - Adamson, Robert AU - Adamson R FAU - Dembitsky, Walter AU - Dembitsky W FAU - Browne, Barry AU - Browne B FAU - Steinberg, Steven AU - Steinberg S LA - eng PT - Case Reports PT - Journal Article PL - United States TA - Clin Transpl JT - Clinical transplants JID - 8812419 RN - 0 (HLA Antigens) RN - 0 (Immunoglobulin G) RN - 0 (Isoantibodies) SB - IM MH - Adult MH - Antibody Specificity MH - Female MH - Graft Rejection/epidemiology/*immunology MH - Graft Survival/immunology MH - HLA Antigens/*immunology MH - Heart Transplantation/*adverse effects MH - Histocompatibility Testing MH - Humans MH - Immunoglobulin Class Switching/immunology MH - Immunoglobulin G/blood/*immunology MH - Isoantibodies/blood/*immunology MH - Kidney Transplantation/*adverse effects MH - Male MH - Risk Factors MH - Seroepidemiologic Studies MH - Tissue Donors EDAT- 2013/01/01 00:00 MHDA- 2014/09/10 06:00 CRDT- 2014/08/07 06:00 PHST- 2014/08/07 06:00 [entrez] PHST- 2013/01/01 00:00 [pubmed] PHST- 2014/09/10 06:00 [medline] PST - ppublish SO - Clin Transpl. 2013:413-22.